Denali Therapeutics Inc.
SEC Filing List
DNLI CIK: 0001714899
| Form | Description | Owner/Filer | Filing Agent | Date | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 05/15/2026 | ||||
| 10-Q | Quarterly report pursuant to Section 13 ... | Denali Therapeutics Inc. | 05/07/2026 | ||
| 8-K | Current report filing | Denali Therapeutics Inc. | 05/07/2026 | ||
| SCHEDULE 13G/A | 05/06/2026 | ||||
| ARS | Annual report to security holders | Denali Therapeutics Inc. | 04/21/2026 | ||
| DEF 14A | Definitive proxy statements | Denali Therapeutics Inc. | 04/21/2026 | ||
| DEFA14A | Definitive additional proxy soliciting m... | Denali Therapeutics Inc. | 04/21/2026 | ||
| 3/A | Amendment to the Initial statement of be... | Chin Peter Scott | Denali Therapeutics Inc. | 04/21/2026 | |
| 3 | Initial statement of beneficial ownershi... | Chin Peter Scott | Denali Therapeutics Inc. | 04/20/2026 | |
| 8-K | Current report filing | Denali Therapeutics Inc. | 04/03/2026 | ||
| No record found. | |||||
| Load More | |||||
